Status
Conditions
Treatments
About
This study investigates families with at least two cases of B-cell lymphoproliferative disorders (LPD), and evaluates the prevalence of LPD in families, the relationship between medical history, genetic factors, and the risk of familial LPD, and various clinical outcomes for these families in a multiethnic population of Jews and Arabs in Israel.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients must have LPD and must have a family history of LPD. LPD patients who signed an informed consent to participate in the study.
Criteria for the inclusion of relatives of patients:
Relatives must be related by blood to LPD patients or unrelated (for control group).
Relatives who signed an informed consent to participate in the study.
Exclusion criteria
1,000 participants in 15 patient groups
Loading...
Central trial contact
Geffen Kleinstern, PhD; Tamar Tadmor, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal